Quest Diagnostics Inc
NYSE:DGX
Net Margin
Quest Diagnostics Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20B USD |
9%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
73.8B EUR |
2%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
85.6B USD |
2%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
84.1B USD |
1%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
28B EUR |
3%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.7B EUR |
2%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD |
6%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
14B EUR |
3%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.9B USD |
7%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
9.3B USD |
9%
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
12.6B AUD |
6%
|
Quest Diagnostics Inc
Glance View
In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Quest Diagnostics Inc's most recent financial statements, the company has Net Margin of 8.8%.
You don't have any saved screeners yet